UnitedHealth Group, US91324P1021

UnitedHealth Group stock trades at EUR 338.70, 15.46 percent below its 52-week high

Published on 10/12/2026 at 16:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 13, 2026. UnitedHealth Group stock costs EUR 338.70 on October 12, 2026, 1.04 percent above October 9 Xetra close.

Key points in brief

  • UnitedHealth Group stock traded at EUR 338.70 at Lang & Schwarz on October 12, 2026.
  • The price stood 1.04 percent above the October 9 Xetra close of EUR 335.20.
  • Market capitalization was EUR 306.2 billion and the P/E ratio was 24.39.
  • UnitedHealth Group is scheduled to report third-quarter 2026 results on October 13, 2026.
Isometrische 3D-Illustration eines Healthcare-Netzwerks mit Krankenhaus, Apotheke und Datenzentrum
UnitedHealth Group US91324P1021 als isometrisches 3D-Netzwerk aus Krankenhaus Apotheke Heim und Datenzentrum, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) traded at EUR 338.70 at Lang & Schwarz on October 12, 2026, at 4:13 p.m. CEST, up EUR 3.50 or 1.04 percent versus the October 9 Xetra close. According to UnitedHealth Group on September 15, 2026, the company will release its third-quarter 2026 results before the market opens on October 13, 2026.

Price stays below yearly high

The euro quotation was EUR 61.90 below its 52-week high of EUR 400.60, a gap of 15.46 percent. The same quote stood EUR 116.00 above the 52-week low of EUR 222.70, placing the stock materially closer to its yearly high than its yearly low.

UnitedHealth Group's market capitalization was EUR 306.2 billion as of October 12, 2026. Its P/E ratio was 24.39, while the quotation had reached a session price of EUR 337.20 in the finance market data at 2:03 p.m. UTC, equivalent to 4:03 p.m. CEST.

Trading activity and valuation

The Lang & Schwarz bid was EUR 338.40 and the ask was EUR 339.00 at 4:13 p.m. CEST. The spread between the two prices was EUR 0.60, while the reference price remained EUR 0.30 below the ask.

For investors in Germany, the key comparison is the Xetra close rather than the US dollar quotation. UnitedHealth Group's euro price was 1.04 percent above that October 9 level, a move that provides a clear same-currency benchmark for the session.

Comparison with peers

UnitedHealth Group: plus 1.04 percent, P/E 24.39, market capitalization EUR 306.2 billion

Humana (NYSE, USD): minus 0.09 percent, P/E 40.98, market capitalization USD 51.8 billion

Elevance Health (NYSE, USD): plus 1.92 percent, P/E 18.69, market capitalization USD 91.2 billion

Next earnings date is October 13

The next scheduled company event is the third-quarter 2026 results release on October 13, 2026, before the US market opens, followed by an 8:00 a.m. ET conference call. The date gives the current valuation a near-term calendar marker without changing the price comparison between Lang & Schwarz and Xetra.

UnitedHealth Group stock at EUR 338.70

UnitedHealth Group stock was trading at EUR 338.70 at Lang & Schwarz on October 12, 2026, at 4:13 p.m. CEST, up 1.04 percent versus the October 9 Xetra close of EUR 335.20. The continuously updated real-time quote of UnitedHealth Group stock.

UnitedHealth Group stock facts

  • Company: UnitedHealth Group, Inc.
  • ISIN: US91324P1021
  • Ticker: UNH
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 12, 2026, 4:13 p.m. CEST: EUR 338.70
  • Change versus Xetra close: plus 1.04 percent
  • Xetra close October 9, 2026: EUR 335.20
  • Market capitalization: EUR 306.2 billion as of October 12, 2026
  • 52-week range: EUR 222.70-400.60 as of October 12, 2026
  • Sector / Industry: Health Care / Managed Care
  • Next earnings date: October 13, 2026

Market context: Market report S&P 500.

More news and analyses on UnitedHealth Group stock

Disclaimer...

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70303744 | bgmi